glp-1 macros GLP-1s and the Future of Food GLP-1 Agonists Market Report 2025-2033,

WeightWatchers joins the market WeightWatchers has been in business for over 60 years and is the name in the U.S

doi: 10.1177/1403494810394715 [DOI] [PubMed] [Google Scholar] 23

As with all litigation, the presence of an MDL or a pending class claim can evolve over time, and anyone considering a claim should consult experienced counsel to understand available legal avenues

In conclusion, GLP-1 inhibits PARP-1 to protect islet cell function against cholesterol-induced toxicity in vitro and in vivo through enhancing cholesterol efflux

Ghrelin regulates GLP-1 production through mTOR signaling in L cells

The Zepbound cases in the GLP-1 federal MDL are moving through expert work on key cross-cutting issues, with expert reports due in early 2026 and expert depositions currently scheduled to be completed by April 10, 2026, followed by Rule 702 motions and summary judgment briefing through mid-2026